Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.
<p>BACKGROUND: The behavioural impact of pharmacogenomics is untested. We tested two hypotheses concerning the behavioural impact of informing smokers their oral dose of NRT is tailored to analysis of DNA.</p><p> METHODS AND FINDINGS: We conducted an RCT with smokers in smoking ces...
Main Authors: | Marteau, T, Aveyard, P, Munafò, MR, Prevost, A, Hollands, G, Armstrong, D, Sutton, S, Hill, C, Johnstone, E, Kinmonth, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2012
|
Similar Items
-
Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.
by: Marteau, T, et al.
Published: (2010) -
Adherence to and consumption of nicotine replacement therapy and the relationship with abstinence within a smoking cessation trial in primary care.
by: Hollands, G, et al.
Published: (2013) -
Factors influencing the impact of pharmacogenomic prescribing on adherence to nicotine replacement therapy: A qualitative study of participants from a randomized controlled trial
by: Wright, A, et al.
Published: (2018) -
Differential efficacy of nicotine replacement among overweight and obese women smokers.
by: Strong, DR, et al.
Published: (2014) -
The effect of nicotine dependence and withdrawal symptoms on use of nicotine replacement therapy: secondary analysis of a randomized controlled trial in primary care
by: Hollands, GJ, et al.
Published: (2021)